Anu Aggarwal, Tamanna K Singh, Michael Pham, Matthew Godwin, Rui Chen, Thomas M McIntyre, Alliefair Scalise, Mina K Chung, Courtney Jennings, Mariya Ali, Hiijun Park, Kristin Englund, Alok A Khorana, Lars G Svensson, Samir Kapadia, Keith R McCrae, Scott J Cameron
BACKGROUND: Postacute sequelae of COVID-19 (PASC), also referred to as "Long COVID", sometimes follows COVID-19, a disease caused by SARS-CoV-2. Although SARS-CoV-2 is well known to promote a prothrombotic state, less is known about the thrombosis risk in PASC. Our objective was to evaluate platelet function and thrombotic potential in patients following recovery from SARS-CoV-2, but with clear symptoms of patients with PASC. METHODS: patients with PASC and matched healthy controls were enrolled in the study on average 15 months after documented SARS-CoV-2 infection...
February 9, 2024: Vascular Medicine